In this study they added an IFN metagene signature to their analyses of high-grade breast cancers and found that the worst prognosis was observed where the tumor was positive for the ECM3 signature but negative for the IFN metagene signature [15]. This evidence concerns the gene IFNA1 and neoplasm.